Literature DB >> 9124550

Regulation of gluconeogenesis by glutamine in normal postabsorptive humans.

G Perriello1, N Nurjhan, M Stumvoll, A Bucci, S Welle, G Dailey, D M Bier, I Toft, T G Jenssen, J E Gerich.   

Abstract

There is evidence that glutamine may act as a regulator of protein, free fatty acid, and glycogen metabolism. To test the hypothesis that glutamine may act as a physiological regulator of gluconeogenesis, we infused 16 normal postabsorptive volunteers with glutamine at a rate (11.4 micromol kg(-1) x min(-1)) estimated to approximate its appearance in plasma after a protein meal and assessed changes in production of glucose from glutamine, systemic glucose appearance and disposal, and uptake and release of glucose, glutamine, and alanine by forearm skeletal muscle. Although infusion of glutamine increased plasma glutamine concentration and turnover only threefold (from 0.63 +/- 0.03 to 1.95 +/- 0.10 mmol/l and from 5.43 +/- 0.24 to 14.85 +/- 0.66 micromol x kg(-1) x min(-1), respectively; P < 0.001), formation of glucose from glutamine increased sevenfold from 0.55 +/- 0.03 to 3.74 +/- 0.28 micromol x kg(-1) x min(-1) (P < 0.001). Formation of glucose from alanine was also stimulated (0.52 +/- 0.05 vs. 0.75 +/- 0.04 micromol x kg(-1) x min(-1); P < 0.001) in the absence of a change in plasma alanine concentration. Furthermore, glutamine infusion decreased its own de novo synthesis (4.55 +/- 0.22 vs. 2.81 +/- 0.62 micromol x kg(-1) x min(-1);P < 0.02) while increasing that of alanine (2.82 +/- 0.32 vs. 3.56 +/- 0.32 micromol x kg(-1) x min(-1); P < 0.002). Systemic glucose appearance, systemic glucose disposal, and forearm balance of glucose and alanine were not altered. Because the stimulatory effects of glutamine on gluconeogenesis occurred in the absence of changes in plasma insulin and glucagon levels, these results provide evidence that, in humans, glutamine may act both as a substrate and as a regulator of gluconeogenesis as well as a modulator of its own metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124550     DOI: 10.1152/ajpendo.1997.272.3.E437

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Oral supplement of six selective amino acids arrest progression renal failure in uremic patients.

Authors:  Hippocrates Yatzidis
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 2.  An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.

Authors:  Javier De Las Heras; Luis Aldámiz-Echevarría; María-Luz Martínez-Chantar; Teresa C Delgado
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-11-28       Impact factor: 4.481

3.  Acute alcohol exposure, acidemia or glutamine administration impacts amino acid homeostasis in ovine maternal and fetal plasma.

Authors:  Shannon E Washburn; Onkar B Sawant; Emilie R Lunde; Guoyao Wu; Timothy A Cudd
Journal:  Amino Acids       Date:  2013-01-12       Impact factor: 3.520

Review 4.  Mitochondrial dysfunction in diabetic kidney disease.

Authors:  Josephine M Forbes; David R Thorburn
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

5.  Growth hormone and insulinlike growth factor 1 promote intestinal uptake and hepatic release of glutamine in sepsis.

Authors:  L Balteskard; K Unneberg; M Mjaaland; T G Jenssen; A Revhaug
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

6.  Glutamine and cystine-enriched diets modulate aquaporins gene expression in the small intestine of piglets.

Authors:  Inês Vieira da Silva; Bárbara P Soares; Catarina Pimpão; Rui M A Pinto; Teresa Costa; João P B Freire; Etienne Corrent; Tristan Chalvon-Demersay; José A M Prates; Paula A Lopes; Graça Soveral
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.